Risk of Major Adverse Cardiovascular Events and Thromboembolism Events in Patients with Psoriatic Arthritis on JAK Inhibitors: A Network Meta-Analysis

Abstract Objectives Our objective was to evaluate the comparative effects of five Janus kinase inhibitors (JAKis) with ten interventions, comparing their impact on major adverse cardiovascular events (MACE) and thromboembolism events (TE) in patients with psoriatic arthritis (PsA) through network me...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Lin-Hong Shi, James Cheng-Chung Wei, William Tao-Hsin Tung
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	Adis, Springer Healthcare 2025-07-01
Serie:	Rheumatology and Therapy
Soggetti:	JAK inhibitor Psoriatic arthritis Major adverse cardiovascular events Thromboembolism events TNFi Network meta-analysis
Accesso online:	https://doi.org/10.1007/s40744-025-00783-5
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!